Medicon Hellas S.A. Cash Flow Conversion Efficiency
Medicon Hellas S.A. cash flow conversion efficiency. Based on the latest financial reports, Medicon Hellas S.A. (MEDIC) has a cash flow conversion efficiency ratio of 0.074x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.25 Million ≈ $1.46 Million USD) by net assets (€16.95 Million ≈ $19.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Medicon Hellas S.A. (2014–2022)
Cash flow conversion efficiency of Medicon Hellas S.A. from 2014 to 2022. This chart illustrates how Medicon Hellas S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View Medicon Hellas S.A. share price for real-time trading data and today's change.
Medicon Hellas S.A. Cash Flow Conversion Ratio Explained
Medicon Hellas S.A. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Medicon Hellas S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medicon Hellas S.A. ranked by their cash flow conversion efficiency. Also see MEDIC stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lepidico Ltd
AU:LPD
|
0.000x |
|
Volt Power Group Ltd
AU:VPR
|
0.043x |
|
Duoback Co. Ltd
KQ:073190
|
-0.023x |
|
Venus Metals Corporation Ltd
AU:VMC
|
-0.014x |
|
Spire Healthcare Group Plc
LSE:SPI
|
0.151x |
|
Rocket One Inc.
NASDAQ:RKTO
|
-0.733x |
|
Coral India Finance & Housing Limited
NSE:CORALFINAC
|
0.048x |
|
Arzum Elektrikli Ev Aletleri Sanayi ve Ticaret AS
IS:ARZUM
|
7.089x |
Annual Cash Flow Conversion Efficiency for Medicon Hellas S.A. (2014–2022)
The table below shows the annual cash flow conversion efficiency of Medicon Hellas S.A. from 2014 to 2022. Review MEDIC free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | €16.95 Million ≈ $19.82 Million |
€1.25 Million ≈ $1.46 Million |
0.074x | -77.95% |
| 2021-12-31 | €14.34 Million ≈ $16.77 Million |
€4.79 Million ≈ $5.60 Million |
0.334x | +19.76% |
| 2020-12-31 | €11.03 Million ≈ $12.89 Million |
€3.07 Million ≈ $3.59 Million |
0.279x | +76.73% |
| 2019-12-31 | €10.26 Million ≈ $11.99 Million |
€1.62 Million ≈ $1.89 Million |
0.158x | -52.07% |
| 2018-12-31 | €9.68 Million ≈ $11.32 Million |
€3.19 Million ≈ $3.73 Million |
0.329x | -46.66% |
| 2017-12-31 | €7.84 Million ≈ $9.16 Million |
€4.84 Million ≈ $5.66 Million |
0.617x | +105.22% |
| 2016-12-31 | €6.12 Million ≈ $7.16 Million |
€1.84 Million ≈ $2.15 Million |
0.301x | +586.69% |
| 2015-12-31 | €5.34 Million ≈ $6.25 Million |
€-330.21K ≈ $-386.05K |
-0.062x | -112.35% |
| 2014-12-31 | €3.58 Million ≈ $4.19 Million |
€1.79 Million ≈ $2.10 Million |
0.500x | -- |
About Medicon Hellas S.A.
Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company distributes various analyzer sysytem for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems. It al… Read more